Wilson, Can J. Physiol. Pharmacol., vol. 75, No. 11-12, pp. 1149-1163 (abstract), Nov. 1997.* |
Agus et al. J. Clin. Invest., vol. 100, No. 11, pp. 2842-2848, Dec. 1997.* |
Welch et al, The American Society of Biochemistry and Molecular Biology, vol. 270, No. 21, pp. 12584-12592, 1995.* |
Vera et al, The American Society of Biolchemistry and Molecular Biology, vol. 270, No. 40, pp. 23705-23712, 1995.* |
Ngkeekwong et al, J. Biochem., vol. 324, pp. 225-230, 1997.* |
Siushansian et al, J. Neurochem., vol. 68. pp. 2378-2385 (abstract), 1997.* |
Challem, Jack, “Vitamin E: High-Doses Reduce The Risk Of Heart Attack” The Nutrition Reporter (May 1996) pp. 1-3. |
Department of Neurology, University of Rochester Medical Center, “Effects Of Tocopherol And Deprenyl On The Progression Of Disability In Early Parkinson's Disease. The Parkinson Study Group” The New England Journal Of Medicine (Jan. 21, 1993) vol. 328(3):176-183. |
Diaz, Marco, N., et al., “Antioxidants And Atherosclerotic Heart Disease” The New England Journal of Medicine (Aug. 7, 1997) vol. 337:408-416. |
Drachman, David, A., “Treatment Of Alzheimer's Disease—Searching For A Breakthrough, Settling For Less” The New England Journal Of Medicine (Apr. 24, 1997) vol. 336:1245-1247. |
Hayashi, Eiichi, et al., “Fundamental Studies on Physiological and Pharmacological Actions of L-Ascorbate 2-Sulfate (IV) On the General Pharmacological Acitons of L-Ascorbate 2-Sulfate” Oyo Yakuri 129(1): 131-138, 1976. |
Jenner, P., “Oxidative Damage In Neurodegenerative Disease” The Lancet (Sep. 17, 1994) vol. 344:796-798n. |
Lethem, Rosemary, et al., “Antioxidants and Dementia” The Lancet (Apr. 26, 1997) vol. 349:1189-1190. |
Patterson, John, W., “The Diabetogenic Effect of Dehydroascorbic and Dehydroisoascorbic Acids”, J. Biol. Chem. 183: 81-88, 1950. |
Patterson, John, ., et al. “Some Effects of Dehydroascorbic Acid on the Central Nervous System”, Am. J. Physiol. 167: 119-126, 1951. |
Peyser, C.E., et al., “Trial Of D-Alpha- Tocopherol In Huntington's Disease” American Journal of Psychiatry (Dec. 1995) vol. 152(12):1771-1775. |
Sano, Mary, et al., “A Controlled Trial Of Selegiline, Alpha-Tocopherol, Or Both As Treatment For Alzheimer's Disease” The New England Journal Of Medicine (Apr. 24, 1997) vol. 336: 1216-1222. |
Siostrand, “Pharmacological Effects of Dehydroascorbic Acid and Ascorbic Acid in Conscious and Anaesthetized Animals” Acta Physiol. Scand. Suppl. 356:1-79, 1970. |
Smith, M. A., et al., “Oxidative Damage In Alzheimer's ” Nature (Jul. 11, 1996) vol. 382:120-121. |
Sorg, Olivier, et al., “Inhibition Of Astrocyte Glutamate Uptake By Reactive Oxygen Species: Role Of Antioxidant Enzymes” Molecular Medicine (Jul. 7, 1997) vol. 3:431-440. |
Tardif, Jean-Claude, et al., “Probucol And Multivitamins In The Prevention Of Restenosis After Coronary Angioplasty” The New England Journal Of Medicine (Aug. 7, 1997) vol. 337:365-372. |
Vera, Juan Carlos, et al., “Mammalian Facilitative Hexose Transporters Mediate The Transport Of Dehydroascorbic Acid” Nature (Jul. 1, 1993) vol. 364:79-82. |
Witztum, Joseph, L., “The Oxidation Hypothesis Of Atherosclerosis” The Lancet (Sep. 17, 1994) vol. 344:793-795. |
Youdim, Moussa, B.H., et al., “Understanding Parkinson's Disease” Scientific American (Jan. 1997) pp. 52-59. |